<p>The Global Alzheimer’s Platform Foundation<em><sup>®</sup></em>, (GAP) is releasing the first results from the Bio-Hermes-001 Study. This study in over 1000 community-based participants from throughout the US compared the results of blood and digital biomarkers with brain amyloid PET scans or cerebrospinal fluid assays. The study<em> </em>revealed a strong correlation between several blood tests, particularly p-tau 217, with the presence of amyloid plaques in the brain, a diagnostic hallmark of Alzheimer’s disease (AD). This relationship was demonstrated across the entire study population including the 24% percent of Bio-Hermes participants from African American, Latino and other traditionally underrepresented communities, an unprecedented level of diversity. These findings will enhance the field’s ability to provide a more economical, timely, and accurate diagnosis of Alzheimer’s disease and s
The confusion and misconceptions surrounding hospice can keep a family from seeking needed care for a loved one. Here is advice on what to expect and when to begin.
Reversing the Trend: Making Clinical Trials More Diverse dmagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dmagazine.com Daily Mail and Mail on Sunday newspapers.